In the last decade, lung cancer has advanced significantly, offering new hope to patients. The discovery of Osimertinib and its benefit in treating lung cancer is an important step towards improving survival rates. Developed by AstraZeneca under the brand name Tagrisso, has been a game-changer in improving survival rates, but...

Cancer treatment can be challenging and expensive. One crucial medication used to treat several types of cancers is Cabozantinib. It works best for patients with kidney and liver cancer. This drug is available in generic and FDA-approved brand versions that doctors prescribe as cancer medications. Cabometyx - Used for renal cell carcinoma...

On October 10, 2024, the Food and Drug Administration (FDA) approved Inavolisib, in combination with Palbociclib and Fulvestrant, for adults with advanced breast cancer that meets specific criteria. This approval is essential for patients who have:Endocrine-resistant breast cancerPIK3CA-mutated tumorsHormone receptor (HR)-positive statusHER2-negative statusLocally advanced or metastatic disease, as identified by an FDA-approved...